Atlas Trials

Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide

Clinical trial NCT00900757 · COMPLETED

Trial details

NCT number
NCT00900757
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Glioma
Start date
2009-08-01
Primary completion
2012-12-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.